The company has to inform the market of its activities. It has done so. Would you have preferred they keep it quite and under wraps...lol
It has said that it will spend $3m over 3 years i.e. $1m per year at one of the most respected and prestigious research bodies in the world to fund ground breaking research in the newly established field of medical cannabis - in return for an exclusive licence over any products. Seems like a pretty smart entry price to me...
What other MC company on the ASX do you know that is lining up like this one?
What other Hemp company on the ASX do you know that is lining up like this one?
Offcourse this announcement on its own is not going to set the SP alight but it sure is helping build a very solid picture of where they are heading imo. If they can fund this from their hemp operations (which it looks like they should be able to do fairly easily then that's great imo)
- Forums
- ASX - By Stock
- CGB
- Ann: A World First for MCL in Autoimmune Disease Reasearch
Ann: A World First for MCL in Autoimmune Disease Reasearch, page-36
Featured News
Add CGB (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online